0001062993-20-004556.txt : 20200917
0001062993-20-004556.hdr.sgml : 20200917
20200917170704
ACCESSION NUMBER: 0001062993-20-004556
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200915
FILED AS OF DATE: 20200917
DATE AS OF CHANGE: 20200917
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: VERU DENNISON T
CENTRAL INDEX KEY: 0001225341
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-21088
FILM NUMBER: 201181804
MAIL ADDRESS:
STREET 1: C/O PALIDADE CAPITAL
STREET 2: ONE BRIDGE PLAZA NORTH #695
CITY: FORT LEE
STATE: NJ
ZIP: 07024
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Brickell Biotech, Inc.
CENTRAL INDEX KEY: 0000819050
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 930948554
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5777 CENTRAL AVENUE
STREET 2: SUITE 102
CITY: BOULDER
STATE: CO
ZIP: 80301
BUSINESS PHONE: (720) 505-4755
MAIL ADDRESS:
STREET 1: 5777 CENTRAL AVENUE
STREET 2: SUITE 102
CITY: BOULDER
STATE: CO
ZIP: 80301
FORMER COMPANY:
FORMER CONFORMED NAME: VICAL INC
DATE OF NAME CHANGE: 19940211
4
1
form4.xml
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
X0306
4
2020-09-15
0000819050
Brickell Biotech, Inc.
BBI
0001225341
VERU DENNISON T
C/O BRICKELL BIOTECH, INC.
5777 CENTRAL AVENUE, SUITE 102
BOULDER
CO
80301
1
0
0
0
Common Stock
2020-09-14
5
G
0
E
19642
0
D
7230
D
Common Stock
2020-09-15
4
A
0
13580
.81
A
20810
D
Common Stock
2020-09-15
4
P
0
15355
.8086
A
36165
D
Common Stock
2020-09-16
4
P
0
14645
.8029
A
50810
D
Common Stock
2020-09-14
5
G
0
E
19642
0
A
980030
I
By self due to Control over the Entity that holds Shares
Stock Option (right to buy)
.80
2020-09-15
4
A
0
60000
0
A
2030-09-15
Common Stock
60000
60000
D
On September 15, 2020, the reporting person was granted 13,580 restricted stock units ("RSUs") in lieu of a portion of cash compensation as a director of Brickell Biotech, Inc. The RSUs are scheduled to vest on December 31, 2020 and will be settled in the form of one share of common stock for each RSU.
Represents the purchase of 15,355 shares in multiple transactions, ranging in price from $0.80 to $0.8153 per share, resulting in a weighted average purchase price of $0.8086. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares purchased at each price within the range.
Represents the purchase of 14,645 shares in multiple transactions, ranging in price from $0.80 to $0.81 per share, resulting in a weighted average purchase price of $0.8029. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares purchased at each price within the range.
The stock options will vest 25% on September 15, 2021, and the remainder will vest in equal monthly installments over the following three years.
/s/ Christine G. Long, Attorney-in-Fact for Dennison T. Veru (power of attorney previously filed)
2020-09-17